Growth Metrics

Novartis Ag (NVS) Other Non-Current Assets (2016 - 2026)

Novartis Ag's Other Non-Current Assets history spans 14 years, with the latest figure at $200.0 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $200.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $200.0 million, a N/A change, with the full-year FY2025 number at $509.0 million, down 85.48% from a year prior.
  • Other Non-Current Assets hit $200.0 million in Q1 2026 for Novartis Ag, down from $509.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for NVS hit a ceiling of $4.5 billion in Q2 2025 and a floor of $200.0 million in Q1 2026.
  • Historically, Other Non-Current Assets has averaged $2.0 billion across 5 years, with a median of $1.2 billion in 2023.
  • Biggest five-year swings in Other Non-Current Assets: surged 303.64% in 2022 and later tumbled 85.48% in 2025.
  • Tracing NVS's Other Non-Current Assets over 5 years: stood at $1.1 billion in 2022, then grew by 8.02% to $1.2 billion in 2023, then soared by 192.33% to $3.5 billion in 2024, then tumbled by 85.48% to $509.0 million in 2025, then plummeted by 60.71% to $200.0 million in 2026.
  • Business Quant data shows Other Non-Current Assets for NVS at $200.0 million in Q1 2026, $509.0 million in Q4 2025, and $4.5 billion in Q2 2025.